Learn how insurers and PBMs use bulk buying and tendering to lower generic drug costs, the risks of supply shortages, and why cash prices are sometimes cheaper.
Providers face growing barriers securing approval for generic medications despite their lower cost. Learn how documentation, electronic systems, and payer policies shape the process-and what’s changing in 2025.